anti-amyloid beta vaccines (Pfizer/JANSSEN Alzheimer Immunotherapy)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameanti-amyloid beta vaccines (Pfizer/JANSSEN Alzheimer Immunotherapy)
Drug Alias Nameanti-amyloid beta vaccines (Wyeth/Elan)anti-amyloid beta vaccines (Wyeth/JANSSEN Alzheimer Immunotherapy)
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccine
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIreland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Alzheimer Immunotherapy (Holding) LtdWyeth LlcElan Corp +[4] 
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A